Strides Pharma Gains After Buying 4 US Drug Approvals to Expand Product Range
Strides Pharma shares went up slightly on April 30 morning after the company announced that its US-based arm has acquired four approved drug applications (ANDAs) for the American market. The share was trading at Rs 657.40 on the BSE, up by 0.74 percent at 09:24 AM. These ANDAs have been purchased from Nostrum Laboratories Inc., […]
Strides Pharma Gains After Buying 4 US Drug Approvals to Expand Product Range Read More »